Royal Ascot Partners (RAP) has operated the Maryland Proton Treatment Center (MPTC) since 2016. The MPTC, located in the University of Maryland’s BioPark in Baltimore, is one of the most advanced proton therapy centers in the world offering pencil-beam technology in a 5-room facility. RAP has deep expertise not only in operational improvements but also in the management of portfolio companies in a variety of industries. RAP has been utilizing its hands-on approach at MPTC. RAP’s team understands the complexities of the proton sector and has been successfully complementing its clinical partner(s) in driving business decisions which have maximized the proton center’s potential.
As the proton market is still in its early adoption stage, RAP has worked vigorously to adopt best practices in patient experience, marketing, physician awareness, operational efficiency, accounting, billing and collections, capital management, business planning, vendor relations, and other non-clinical aspects of its proton treatment center. The RAP team believes the patient is at the heart of everything the Center does and has a patient centric model to strive towards excellence of care for both the patient and his/her family.
To learn more about the Maryland Proton Treatment Center, please visit their website here.
Royal Ascot Partners is structured to manage non-clinical operations for multiple proton centers around the country and has an interest in learning about current or future proton centers. Please contact firstname.lastname@example.org for any questions or comments relating to our services.